Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
552,621,317
-
Share change
-
+69,296,995
-
Total reported value
-
$5,636,174,609
-
Put/Call ratio
-
51%
-
Price per share
-
$10.20
-
Number of holders
-
419
-
Value change
-
+$724,238,731
-
Number of buys
-
172
-
Number of sells
-
165
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2023
As of 30 Sep 2023,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
419 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
552,621,317 shares.
The largest 10 holders included
BlackRock Inc., Ion Asset Management Ltd., Phoenix Holdings Ltd., Lingotto Investment Management LLP, Clal Insurance Enterprises Holdings Ltd, MENORA MIVTACHIM HOLDINGS LTD., Harel Insurance Investments & Financial Services Ltd., Migdal Insurance & Financial Holdings Ltd., Slate Path Capital LP, and Rubric Capital Management LP.
This page lists
425
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.